Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

4,269 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    Federal Government Launches Consultation On "Patent Box Regime"

    The federal government is currently seeking public opinions on the possibility of instituting a "patent box regime".
    CanadaIntellectual Property
    Oyen Wiggs Green & Mutala
    Oyen Wiggs Green & Mutala
  • Article

    Getting Your Patent Application Into The Fast Lane: Canada's Patent Prosecution Highway

    The success of the program has resulted in foreign patent office participation being extended.
    CanadaIntellectual Property
    Smart & Biggar
    Smart & Biggar
Article

notre revue des changements récents et à venir en droit des brevets est maintenant disponible

notre revue des changements récents et à venir en droit des brevets est maintenant disponible
CanadaIntellectual Property
Fasken (French)
Fasken (French)
  • Article

    Patent Litigation In 2014

    A recent report shows interesting trends in US patent litigation.
    CanadaIntellectual Property
    Field Law
    Field Law
  • Article

    Picking Courts: Forum-Selection In License Agreements

    Any well-drafted technology or patent license agreement will contain dispute resolution provisions that may cover a number of things: such as picking a governing law in case of disputes, mandating arbitration or other alternatives to litigation, or even picking the courts or "forum" in which disputes will be heard - known as a "forum selection clause".
    CanadaIntellectual Property
    Field Law
    Field Law
  • Article

    Proposed Legislation For Patent Term Adjustment, And The Interplay With CSPs

    Bill C-47, "An Act to implement certain provisions of the budget tabled in Parliament on March 28, 2023," aka "Budget Implementation Act, 2023, No. 1" is an omnibus bill that includes proposed amendments...
    CanadaIntellectual Property
    Smart & Biggar
    Smart & Biggar
  • Article

    Revised NOC Regulations To Come Into Force On September 21, 2017

    The Government of Canada has announced that the amended NOC regulations will come into force on September 21, 2017.
    CanadaIntellectual Property
    McCarthy Tétrault
    McCarthy Tétrault
  • Article

    Supreme Court Of Canada Leave Applications - May 2020

    As previously reported, the Federal Court of Appeal (FCA) dismissed Pfizer's appeal from a decision granting Pharmascience's motion for a summary trial on Pfizer's defence of ex turpi causa...
    CanadaIntellectual Property
    Smart & Biggar
    Smart & Biggar
  • Article

    The New Patent Rules Are In Force

    New Patent Rules have come into force in Canada, marking the completion of Canada's long journey to modernize its patent legislative regime.
    CanadaIntellectual Property
    Oyen Wiggs Green & Mutala
    Oyen Wiggs Green & Mutala
  • Article

    The Supreme Court Of Canada Holds Pfizer’s Viagra Patent Invalid

    In a cautionary tale to be heeded by patent drafters, the Supreme Court of Canada held that Pfizer’s patent directed to sildenafil, better known as Viagra, is invalid.
    CanadaIntellectual Property
    Gowling WLG
    Gowling WLG
  • Article

    Innovation In Limbo: A Disappointing Turn In The Benjamin Moore Saga

    In our last comment on non-patentable subject matter, we provided our thoughts on the Federal Court of Appeal's decision in Canada (Attorney General) v Benjamin Moore & Co (the "Benjamin Moore Appeal").
    CanadaLitigation, Mediation & Arbitration
    Lenczner Slaght
    Lenczner Slaght
  • Article

    Canadian Intellectual Property Office Extends Deadlines In View Of COVID-19 Outbreak

    In view of the COVID-19 outbreak, the Canadian Intellectual Property Office (CIPO) has announced that patent, trademark,...
    CanadaCoronavirus (COVID-19)
    Smart & Biggar
    Smart & Biggar
  • Article

    Recent Amendments To The Canadian Patent Act In Response To COVID-19

    The COVID-19 Emergency Response Act, effective March 25, 2020, contains several additions to the Patent Act (Canada)
    CanadaCoronavirus (COVID-19)
    MLT Aikins LLP
    MLT Aikins LLP
  • Article

    WIPO Issues Reassurance In View Of Global Covid-19 Crisis

    On April 7th, 2020, the World Intellectual Property Office (WIPO) issued a statement reassuring its stakeholders that it is well positioned to endure the great uncertainty caused by...
    CanadaCoronavirus (COVID-19)
    Oyen Wiggs Green & Mutala
    Oyen Wiggs Green & Mutala
  • Article

    A Generic Drug Subject To The Patented Medicines Prices Review Board?

    In early June, the Patented Medicines Prices Review Board (PMPRB) released a decision finding that ratiopharm Inc., a generic pharmaceutical company, had sold its ratio Salbutamol HFA product at an excessive price from September 2002 to January 2010.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Fasken
    Fasken
  • Article

    Federal Court Of Appeal Confirms Obviousness Finding In Section 8 Bortezomib Action Against Teva

    As previously reported, the Federal Court granted Teva's claim for compensation under section 8 of the Patented Medicines (Notice of Compliance) Regulations relating to Teva's bortezomib product...
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Article

    Federal Court Of Appeal Dismisses Pfizer's Appeal Of Interlocutory Decision In Pregabalin Section 8 Case: Infringement Not A Viable Defence Where Patentee Did Not Sue In Real World

    As previously reported, Justice O'Reilly of the Federal Court granted Pharmascience's motion for a summary trial on Pfizer's defence of ex turpi causa in an action for section 8 damages related to...
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Article

    Supreme Court Of Canada Dismisses Apotex And Pharmascience's Applications For Leave To Appeal Paliperidone Inducing Infringement Decisions

    As previously reported, the Federal Court of Appeal dismissed two decisions relating to paliperidone palmitate (Janssen's INVEGA SUSTENNA)...
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Article

    Supreme Court Of Canada To Hear Appeal On Patent Utility

    The Supreme Court of Canada has today granted AstraZeneca leave to appeal a Federal Court of Appeal decision, affirming a trial decision invalidating its patent relating to its successful esomeprazole drug (NEXIUM) for lack of utility.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Article

    Updated PMPRB Guidelines Expected In Summer 2025 And NPDUIS Releases Ninth Edition Of The Meds Entry Watch Report

    In the Patented Medicine Prices Review Board (PMPRB)'s June 2025 NEWSletter, Acting Chairperson Anie Perrault confirms that the PMPRB plans on publishing its final Guidelines in summer 2025.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Showing 281–300 of 4269 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics